Liminatus Pharma, Inc. (LIMN)
0.2028
0.00 (0.00%)
USD |
NASDAQ |
May 08, 16:00
0.201
0.00 (0.00%)
After-Hours: 20:00
Liminatus Pharma Total Assets (Quarterly) : 0.5128M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Oruka Therapeutics, Inc. | 488.62M |
| MapLight Therapeutics, Inc. | 479.51M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | 1.436B |
| Insight Molecular Diagnostics, Inc. | 25.76M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.33M |
| Shareholders Equity (Quarterly) | -9.815M |
| Debt to Equity Ratio | -0.147 |
| Current Ratio | 0.0486 |
| Net Debt Paydown Yield | 3.79% |